|
|
 |
|
Viewing report
|
|
|
|
Amylin Pharmaceuticals Inc - SWOT Analysis
Datamonitor, March 2008, Pages: 37
Our Amylin Pharmaceuticals Inc - SWOT Analysis Company Profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
Amylin Pharmaceuticals (Amylin) engages in the discovery, development and commercialization of potential drug candidates for the treatment of diabetes and obesity. The company primarily focuses on investigating the potential utility of new peptide hormone candidates for the treatment of psychiatric indications. It has two marketed products in its portfolio, namely, Byetta and Symlin, for the treatment of diabetes. Amylin primarily operates in the US and Germany. The company is headquartered in San Diego, California and employed 1,550 people as of December 2006. The company recorded revenues of $781 million during the fiscal year ended December 2007, an increase of 52.9% over 2006. The operating loss of the company was $243 million during fiscal year 2007, compared to an operating loss of $237.4 million in 2006. The net loss was $211.1 million in fiscal year 2007, compared to a net loss of $218.9 in 2006. http://investors.amylin.com/phoenix.zhtml?c=101911&p=irol-newsArticle&ID=1100812&highlight=
Scope of the Report
- Provides all the crucial company information required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement
Reasons to Purchase
- Support sales activities by understanding your customers’ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available
Customers who bought this item also bought
Novell, Inc. - Company Analysis
2006 U.S. Pesticide Industry Report
Company Analysis - Adobe Systems Inc.
Red Hat, Inc. - Company Analysis
McAfee Inc. Company Analysis
Astellas Pharma Inc Deals Briefings
RSA Security Inc. - Company Analysis
Watson Pharmaceuticals Inc Deals Briefing
|
|
|
|
